Search for an ETF or holding
Exicure, Inc. (XCUR) is an American company in the healthcare sector, listed on NASDAQ. Market capitalization of 20 million USD (micro-cap).
Exicure, Inc. does not have significant operations. Previously, it focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. The company has a co-development agreement with Adbiotech Co., Ltd. to explore combination therapies based on Burixafor (GPC-100) across multiple therapeutic areas. Exicure, Inc. was founded in 2011 and is headquartered in Redwood City, California.